ARISTOTLE was a randomised, double-blind trial, where ELIQUIS ® (at a dose of 5 mg twice... Read more
Like other AAS, boldenone is an agonist of the androgen receptor (AR).  The activity of boldenone is mainly anabolic , with a low androgenic potency. Boldenone will increase nitrogen retention, protein synthesis, increases appetite and stimulates the release of erythropoietin in the kidneys.  Boldenone was synthesized in an attempt to create a long-acting injectable metandienone , for androgen deficiency disorders. Boldenone acts similar to metandienone with fewer adverse androgenic effects. [ medical citation needed ] Although commonly compared to nandrolone , boldenone lacks progesterone receptor interaction and associated progestogenic side effects.
Sean hold a Master’s of Business Administration from City University Business School and a Bachelor of Arts in Physics from Oxford University (Holroyd Scholar). He is a member of the SEG, EAGE and PESGB. Follow Us